BERTERO, Luca

BERTERO, Luca  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 108 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
A 68-Year-Old Woman with A Left Orbital and Temporal Mass 2018 Bertero, Luca; Zenga, Francesco; Maletta, Francesca; Senetta, Rebecca; Cassoni, Paola
The adverse impact of the COVID-19 pandemic on abdominal emergencies: A retrospective clinico-pathological analysis 2021 Vissio E.; Falco E.C.; Scozzari G.; Scarmozzino A.; Trinh D.A.A.; Morino M.; Papotti M.; Bertero L.; Cassoni P.
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 2018 Osella-Abate, Simona; Mereu, Elisabetta; Pellegrino, Elisa; Bergaggio, Elisa; Ribero, Simone; Bertero, Luca; Lisa, Francesco; Fierro, Maria Teresa; Papotti, Mauro Giulio; Piva, Roberto*
Angiocentric glioma-associated seizures: The possible role of EATT2, pyruvate carboxylase and glutamine synthetase 2021 Buccoliero A.M.; Caporalini C.; Scagnet M.; Mussa F.; Giordano F.; Sardi I.; Migliastro I.; Moscardi S.; Conti V.; Barba C.; Antonelli M.; Gianno F.; Rossi S.; Diomedi-Camassei F.; Gessi M.; Donofrio V.; Bertero L.; Giangaspero F.; Santi M.; Aronica E.; Genitori L.; Guerrini R.
Anti-Angiogenic Approaches to Malignant Gliomas. 2012 R. Soffietti;E. Trevisan;L. Bertero;C. Bosa;R. Rudà
Antiangiogenic therapy of brain tumors: The role of bevacizumab 2014 Trevisan, Elisa; Bertero, Luca; Bosa, Chiara; Magistrello, Michela; Pellerino, Alessia; Rudà, Roberta; Soffietti, Riccardo
Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices 2018 Mariani, Sara; Bertero, Luca*; Coppola, Vittoria; Saracco, Giorgio; Arezzo, Alberto; Francia Di Celle, Paola; Metovic, Jasna; Marchiò, Caterina; Cassoni, Paola
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) 2014 Soffietti R; Trevisan E; Bertero L; Cassoni P; Morra I; Fabrini MG; Pasqualetti F; Lolli I; Castiglione A; Ciccone G; Rudà R
Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis 2020 Borella, Fulvio; Bertero, Luca; Morrone, Antonio; Gambella, Alessandro; Bovetti, Marialuisa; Cosma, Stefano; Carosso, Andrea; Katsaros, Dionyssios; Gemmiti, Silvia; Preti, Mario; Valabrega, Giorgio; Scotto, Giulia; Cassoni, Paola; Benedetto, Chiara
Caveolin 1 expression favors tumor growth and is associated with poor survival in primary lung adenocarcinomas 2017 Duregon, Leonora; Senetta, Rebecca; Bertero, Luca; Bussolati, Benedetta; Annaratone, Laura; Pittaro, Alessandra; Papotti, Mauro; Marchiò, Caterina; Cassoni, Paola
Caveolin-1 expression predicts favourable outcome and correlates with PDGFRA mutations in gastrointestinal stromal tumours (GISTs) 2021 Bertero, Luca; Gambella, Alessandro; Barreca, Antonella; Osella-Abate, Simona; Chiusa, Luigi; Francia di Celle, Paola; Lista, Patrizia; Papotti, Mauro; Cassoni, Paola
Caveolin-1 in Kidney Chronic Antibody-Mediated Rejection: An Integrated Immunohistochemical and Transcriptomic Analysis Based on the Banff Human Organ Transplant (B-HOT) Gene Panel 2021 Gambella, Alessandro; Barreca, Antonella; Osella-Abate, Simona; Bottasso, Emanuel; Giarin, Manuela Maria; Papotti, Mauro; Biancone, Luigi; Metovic, Jasna; Collemi, Giammarco; Cassoni, Paola; Bertero, Luca
Childhood-onset multiple self-injurious behaviors in Gilles de la Tourette syndrome 2009 Cavanna, Andrea E.; Cavanna, Stefano; Bertero, Luca; Monaco, Francesco; Critchley, Hugo D.
Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults. 2020 Pellerino A, Bertero L, RudA R, Soffietti R
Classification of Tumours of the Central Nervous System 2019 Luca Bertero; Paola Cassoni
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis 2021 Metovic J.; Bragoni A.; Osella-Abate S.; Borella F.; Benedetto C.; Gualano M.R.; Olivero E.; Scaioli G.; Siliquini R.; Ferrando P.M.; Bertero L.; Sapino A.; Cassoni P.; Castellano I.
Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? 2022 Alessia Pellerino, Francesco Bruno, Rosa Palmiero, Edoardo Pronello, Luca Bertero, Riccardo Soffietti, Roberta Rudà
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis 2022 Zhu, Lucía; Retana, Diana; García-Gómez, Pedro; Álvaro-Espinosa, Laura; Priego, Neibla; Masmudi-Martín, Mariam; Yebra, Natalia; Miarka, Lauritz; Hernández-Encinas, Elena; Blanco-Aparicio, Carmen; Martínez, Sonia; Sobrino, Cecilia; Ajenjo, Nuria; Artiga, Maria-Jesus; Ortega-Paino, Eva; Torres-Ruiz, Raúl; Rodríguez-Perales, Sandra; Soffietti, Riccardo; Bertero, Luca; Cassoni, Paola; Weiss, Tobias; Muñoz, Javier; Sepúlveda, Juan Manuel; González-León, Pedro; Jiménez-Roldán, Luis; Moreno, Luis Miguel; Esteban, Olga; Pérez-Núñez, Ángel; Hernández-Laín, Aurelio; Toldos, Oscar; Ruano, Yolanda; Alcázar, Lucía; Blasco, Guillermo; Fernández-Alén, José; Caleiras, Eduardo; Lafarga, Miguel; Megías, Diego; Graña-Castro, Osvaldo; Nör, Carolina; Taylor, Michael D; Young, Leonie S; Varešlija, Damir; Cosgrove, Nicola; Couch, Fergus J; Cussó, Lorena; Desco, Manuel; Mouron, Silvana; Quintela-Fandino, Miguel; Weller, Michael; Pastor, Joaquín; Valiente, Manuel
Clinico-pathological features of gynecological myopericytoma: a challenging diagnosis in an exceptional location 2019 Borella F.; Lucchino F.; Bertero L.; Ribotta M.; Castellano I.; Carosso A.; Cosma S.; Katsaros D.; Benedetto C.
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 2019 Rudà, Roberta; Pellerino, Alessia; Pace, Andrea; Carapella, Carmine Maria; Dealis, Cristina; Caroli, Manuela; Faedi, Marina; Bello, Lorenzo; Migliore, Enrica; Marchese, Giulia; Bertero, Luca; Cassoni, Paola; Soffietti, Riccardo